Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.

Kugathasan S, Denson LA, Walters TD, Kim MO, Marigorta UM, Schirmer M, Mondal K, Liu C, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R, Kappelman MD, Steiner S, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley AR, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Trapnell BC, Sylvester FA, Stephens MC, Baldassano RN, Markowitz JF, Cho J, Xavier RJ, Huttenhower C, Aronow BJ, Gibson G, Hyams JS, Dubinsky MC.

Lancet. 2017 Apr 29;389(10080):1710-1718. doi: 10.1016/S0140-6736(17)30317-3. Epub 2017 Mar 2.

PMID:
28259484
2.

Fecal microbiota transplantation in children: a brief review.

Hourigan SK, Oliva-Hemker M.

Pediatr Res. 2016 Jul;80(1):2-6. doi: 10.1038/pr.2016.48. Epub 2016 Mar 16. Review.

PMID:
26982451
3.

Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.

Hourigan SK, Sears CL, Oliva-Hemker M.

Inflamm Bowel Dis. 2016 Apr;22(4):1020-5. doi: 10.1097/MIB.0000000000000666. Review.

4.

Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.

Hourigan SK, Chen LA, Grigoryan Z, Laroche G, Weidner M, Sears CL, Oliva-Hemker M.

Aliment Pharmacol Ther. 2015 Sep;42(6):741-52. doi: 10.1111/apt.13326. Epub 2015 Jul 21.

5.

Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping.

Cutler DJ, Zwick ME, Okou DT, Prahalad S, Walters T, Guthery SL, Dubinsky M, Baldassano R, Crandall WV, Rosh J, Markowitz J, Stephens M, Kellermayer R, Pfefferkorn M, Heyman MB, LeLeiko N, Mack D, Moulton D, Kappelman MD, Kumar A, Prince J, Bose P, Mondal K, Ramachandran D, Bohnsack JF, Griffiths AM, Haberman Y, Essers J, Thompson SD, Aronow B, Keljo DJ, Hyams JS, Denson LA; PRO-KIIDS Research Group, Kugathasan S.

PLoS One. 2015 Jun 22;10(6):e0128074. doi: 10.1371/journal.pone.0128074. eCollection 2015.

6.

Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort.

Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, Griffiths A, Cabrera J, Otley A, Rick J, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Carvalho R, Keljo D, Pfefferkorn M, Faubion W Jr, Kappelman M, Sudel B, Schaefer ME, Markowitz J, Hyams JS.

J Pediatr. 2015 Sep;167(3):527-32.e1-3. doi: 10.1016/j.jpeds.2015.04.045. Epub 2015 May 15.

PMID:
25982142
7.

Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease.

Grossi V, Lerer T, Griffiths A, LeLeiko N, Cabrera J, Otley A, Rick J, Mack D, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Boyle B, Oliva-Hemker M, Keljo D, Pfefferkorn M, Faubion W, Kappelman MD, Sudel B, Markowitz J, Hyams JS.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1748-56. doi: 10.1016/j.cgh.2015.04.010. Epub 2015 Apr 21.

PMID:
25911120
8.

Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.

Sunseri W, Hyams JS, Lerer T, Mack DR, Griffiths AM, Otley AR, Rosh JR, Carvalho R, Grossman AB, Cabrera J, Pfefferkorn MD, Rick J, Leleiko NS, Hitch MC, Oliva-Hemker M, Saeed SA, Kappelman M, Markowitz J, Keljo DJ; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

Inflamm Bowel Dis. 2014 Aug;20(8):1341-5. doi: 10.1097/MIB.0000000000000102.

PMID:
24983976
9.

Two single group, prospective, baseline-controlled feeding studies in infants and children with chronic diarrhea fed a hypoallergenic free amino acid-based formula.

Borschel MW, Antonson DL, Murray ND, Oliva-Hemker M, Mattis LE, Kerzner B, Tolia V, Baggs G.

BMC Pediatr. 2014 May 29;14:136. doi: 10.1186/1471-2431-14-136.

10.

Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease.

Goyal A, Hyams JS, Lerer T, Leleiko NS, Otley AR, Griffiths AM, Rosh JR, Cabrera JM, Oliva-Hemker MM, Mack DR, Rick JN, Pfefferkorn MD, Carvalho R, Grossman AB, Hitch MC, Sudel B, Kappelman MD, Saeed SA, Faubion WA, Schaefer ME, Markowitz JF, Keljo DJ; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):321-3. doi: 10.1097/MPG.0000000000000409.

PMID:
24796799
11.

The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease.

Hourigan SK, Oliva-Hemker M, Hutfless S.

Dig Dis Sci. 2014 Sep;59(9):2222-7. doi: 10.1007/s10620-014-3169-4. Epub 2014 May 1.

PMID:
24788321
12.

Evaluation of a free amino acid-based formula in infants with presumptive food protein-induced proctocolitis.

Borschel MW, Antonson DL, Murray ND, Oliva-Hemker M, Mattis LE, Baggs GE.

SAGE Open Med. 2014 Sep 20;2:2050312114551857. doi: 10.1177/2050312114551857. eCollection 2014.

13.

Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.

Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS; PRO-KIIDS Research Group.

Gastroenterology. 2014 Feb;146(2):383-91. doi: 10.1053/j.gastro.2013.10.027. Epub 2013 Oct 23.

PMID:
24162032
14.

Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Hourigan SK, Chirumamilla SR, Ross T, Golub JE, Rabizadeh S, Saeed SA, Elson CO, Kelly CP, Carroll KC, Oliva-Hemker M, Sears C.

Inflamm Bowel Dis. 2013 Dec;19(13):2744-52. doi: 10.1097/01.MIB.0000435434.53871.36.

PMID:
24145927
15.

TGFβ receptor mutations impose a strong predisposition for human allergic disease.

Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, Chichester K, Myers L, Halushka MK, Oliva-Hemker M, Wood RA, Dietz HC.

Sci Transl Med. 2013 Jul 24;5(195):195ra94. doi: 10.1126/scitranslmed.3006448.

16.

Magnet ingestions in children presenting to US emergency departments, 2002-2011.

Abbas MI, Oliva-Hemker M, Choi J, Lustik M, Gilger MA, Noel RA, Schwarz K, Nylund CM.

J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):18-22. doi: 10.1097/MPG.0b013e3182952ee5.

PMID:
23575300
17.

Infliximab for the treatment of pediatric ulcerative colitis.

Bradley GM, Oliva-Hemker M.

Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):659-65. doi: 10.1586/egh.12.53. Review.

PMID:
23237250
18.

Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis.

Zeisler B, Lerer T, Markowitz J, Mack D, Griffiths A, Bousvaros A, Keljo D, Rosh J, Evans J, Kappelman M, Otley A, Kay M, Grossman A, Saeed S, Carvalho R, Oliva-Hemker M, Faubion W, Sudel B, Pfefferkorn M, Ashai-Khan F, Leleiko N, Hyams J; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2013 Jan;56(1):12-8. doi: 10.1097/MPG.0b013e31826ac41a.

PMID:
22847466
19.

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

Bradley GM, Oliva-Hemker M.

Biologics. 2012;6:125-34. doi: 10.2147/BTT.S31833. Epub 2012 Jun 5.

20.

Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.

Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson MS, Duerr RH, Silverberg MS, Rioux JD, Taylor KD, Nguyen GC, Wu Y, Datta LW, Hooker S, Dassopoulos T, Kittles RA, Kao LW, Brant SR.

Inflamm Bowel Dis. 2012 Dec;18(12):2277-87. doi: 10.1002/ibd.22931. Epub 2012 Mar 12.

Supplemental Content

Loading ...
Support Center